INCOME TAXES - Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2019 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
Income Tax Disclosure [Abstract] | |||
Income tax provision at the federal statutory rate of 21% (35% for 2017) | $ 103,847 | $ 159,927 | $ 23,435 |
State income taxes, net of effect of federal tax benefit | 6,146 | 16,794 | 782 |
Stock-based compensation | (135,179) | (129,654) | (358,901) |
Research credits | (33,377) | (14,276) | (6,947) |
Realization of certain deferred tax assets | (9,281) | (13,200) | (3,133) |
Foreign income taxed at a different statutory tax rate | (3,333) | (3,206) | (14,725) |
Deferred tax adjustment for enacted changes in tax laws and rates | 890 | (7,488) | 705 |
Non-deductible impairments for certain cost method investments | 2,669 | ||
Transition tax | 0 | (9,190) | 62,667 |
Withholding taxes | 7,304 | 5,165 | 562 |
Other, net | 13,674 | (1,061) | 1,836 |
Income tax (benefit) provision | $ (49,309) | $ 3,811 | $ (291,050) |
X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Realization of Deferred Tax Assets No definition available.
|
X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Transition Tax No definition available.
|
X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Withholding Taxes, Amount No definition available.
|
X | ||||||||||
- Definition Income Tax Reconciliation, Nondeductible Expense, Impairment Losses Related To Cost Method Investments No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|